ArticleJournal of translational medicine2021

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.

Zhuonan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.